<DOC>
	<DOCNO>NCT02649660</DOCNO>
	<brief_summary>This study aim evaluate whether platelet biochemically functionally alter Fabry disease ( FD ) therefore possibly implicate FD manifestation cerebrovascular event . To test hypothesis investigator aim compare platelet plasma lipid profile , well platelet function coagulation parameter FD patient healthy control .</brief_summary>
	<brief_title>Lipidomics Functional Analyses Platelets Fabry Disease</brief_title>
	<detailed_description>Fabry disease ( FD ) severe X-linked inborn error lysosomal glycosphingolipid metabolism . FD patient significantly increase risk cardiac cerebrovascular event , also occur early absence typical FD symptom . However , pathophysiological mechanism lead vascular occlusion ischemia FD largely unclear . Prevention recurrent cerebrovascular event usually base empirical anti-platelet therapy . Prothrombotic state partially activate platelet report FD patient . Platelets contain glycosphingolipids , include globotriaosylceramide ( Gb3 ) , lysosomal α-galactosidase activity . To investigate whether lack reduce α-galactosidase enzyme activity present Fabry disease affect platelet lipid metabolism investigator plan perform LC-MS-based lipidomics analyse platelet plasma FD patient healthy control . To assess whether platelet functionally alter FD , investigator aim determine activation status , activability , aggregability parameter along plasma marker coagulation use flow cytometry , aggregometry immunoassay .</detailed_description>
	<mesh_term>Fabry Disease</mesh_term>
	<criteria>Healthy Volunteers : without know cardiovascular , cerebrovascular renal disease without known condition affect platelet function , blood coagulation lipid metabolism . Patients : Genetically confirm Fabry Disease Adult person ( 1865 year old ) , female male Informed write consent Failure meet inclusion criterion Pregnancy ( declare study participant , pregnancy test perform )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Fabry Disease</keyword>
	<keyword>Platelets</keyword>
	<keyword>Lipidomics</keyword>
	<keyword>Sphingolipids</keyword>
	<keyword>α-Galactosidase A</keyword>
	<keyword>Globotriaosylceramide</keyword>
	<keyword>Gb3</keyword>
	<keyword>GL-3</keyword>
	<keyword>CD77</keyword>
	<keyword>Alpha-galactosidase</keyword>
	<keyword>Platelet activation</keyword>
	<keyword>Lysosomal storage disease</keyword>
	<keyword>LysoGb3</keyword>
	<keyword>Spingosine-1-Phosphate</keyword>
	<keyword>Platelet function</keyword>
	<keyword>CD62P</keyword>
	<keyword>P-selectin</keyword>
</DOC>